Trametinib

Trametinib is a medication used to treat certain types of cancer, particularly melanoma with a specific genetic mutation called BRAF. It works by inhibiting proteins involved in cell growth and division, effectively slowing down or stopping the cancer's spread. Trametinib is often used in combination with other targeted therapies for better results. Administered as a pill, it aims to improve patient outcomes and prolong survival by specifically targeting the cancer's biological pathways, reflecting a personalized approach to cancer treatment. Patients should discuss its use and potential side effects with their healthcare providers.